RAYMOND HALSTEAD: Open Payments
NPI 1548742927 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,662 in 46 payments from 11 companies in 2025. Trend: 2023 $11,877 · 2024 $6,339 · 2025 $3,662
Speaker / faculty: $1,750Food & beverage: $1,036Travel & lodging: $876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $2,801 |
| Insmed, Inc. | 18 | $395 |
| ViiV Healthcare Company | 9 | $185 |
| Merck Sharp & Dohme LLC | 5 | $120 |
| MIMEDX Group, Inc. | 1 | $45 |
| La Jolla Pharmaceutical Company | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| CorMedix Inc. | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
Products named: DALVANCE, Arikayce, DOVATO, ZERBAXA, PIFELTRO, ZEVTERA, MAVYRET, PREVYMIS.
Industry payments across FL — which companies pay providers there.
